Verition Fund Management
PACB icon

Verition Fund Management’s Pacific Biosciences PACB Stock Holding History

Verition Fund Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-201,475
Closed -$369K – 3620
2024
Q4 		$369K Buy
+201,475
New +$393K ﹤0.01% 2658
2024
Q2 		– Sell
-14,316
Closed -$53.7K – 3191
2024
Q1 		$53.7K Buy
+14,316
New +$83.8K ﹤0.01% 2627
2023
Q4 		– Sell
-31,800
Closed -$266K – 2596
2023
Q3 		$266K Buy
+31,800
New +$363K ﹤0.01% 1813
2023
Q1 		– Sell
-15,382
Closed -$126K – 2457
2022
Q4 		$126K Sell
15,382
-8,063
-34% -$69.5K ﹤0.01% 1824
2022
Q3 		$136K Buy
+23,445
New +$135K ﹤0.01% 2568
2018
Q4 		– Sell
-23,697
Closed -$128K – 1136
2018
Q3 		$128K Hold
23,697
– – ﹤0.01% 1200
2018
Q2 		$84K Hold
23,697
– – 0.01% 1032
2018
Q1 		$49K Buy
+23,697
New +$61.5K ﹤0.01% 1076
2016
Q3 		– Sell
-15,000
Closed -$106K – 1258
2016
Q2 		$106K Buy
+15,000
New +$137K 0.01% 828
2015
Q3 		– Sell
-16,585
Closed -$96K – 672
2015
Q2 		$96K Buy
+16,585
New +$96K 0.02% 552
2014
Q1 		– Sell
-137,918
Closed -$721K – 612
2013
Q4 		$721K Buy
137,918
+105,394
+324% +$484K 0.13% 118
2013
Q3 		$180K Sell
32,524
-22,676
-41% -$78.7K 0.03% 468
2013
Q2 		$139K Buy
+55,200
New +$137K 0.03% 530

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verition Fund Management's PACB Position: Q1 2025 in Review

Verition Fund Management sold out of Pacific Biosciences (PACB) in Q1 2025, closing a stake of 201,475 shares — an estimated $369K sold.

Verition Fund Management first reported a position in PACB in Q2 2013 and held it in 13 quarters. The position peaked at $721K in Q4 2013. 225 funds tracked by Wall St. Rank hold PACB as of Q1 2025.

  • Verition Fund Management reported no remaining Pacific Biosciences position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 201,475 Pacific Biosciences shares in Q1 2025, an estimated $369K.
  • Verition Fund Management first reported a position in Pacific Biosciences in Q2 2013 and held it in 13 quarters.
  • Verition Fund Management's Pacific Biosciences position peaked at $721K in Q4 2013.
  • 225 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.